APAC Blood Group Typing Market Size & Growth (2021 to 2026):
The Asia Pacific Blood Group Typing Market size is anticipated to grow at 11.31 % CAGR from 2021 to 2026 and it is expected that the Asia Pacific Market is valued at USD 0.45 billion in 2021 and is expected to reach USD 0.76 billion by 2026.
DRIVERS
The increasing number of blood donation activities and the increasing incidence of trauma, accidents and surgeries requiring blood transfusion are expected to drive the blood group market for years to come. In addition, the growing demand for blood groups in prenatal and post natal testing and the stringency of prudent blood transfusions await a market boost in the years to come. In addition, the growing importance of forensic studies and blood group requirements in forensic studies and examinations is expected to drive the market over the anticipated period.
The growing number of donated blood and the growing number of patients requiring transfusions due to accidents and trauma are the major factors driving the blood group market. Blood group is also crucial in detecting the condition of hemolytic disease of the newborn (HDN) in pregnant women, thus driving the demand for such tests.
The advent of new molecular diagnostic tools that facilitate rapid and reliable group identification in a large blood sample is expected to provide many opportunities for market players. For example, molecular genotyping of ABO blood groups in large populations can be performed using these methods. Identifying the blood group is also important for genetic disorders for neonates, as it prevents the newborn from being exposed to anemia. The APAC blood group market has experienced increased growth due to technological advancements in the healthcare industry.
RESTRAINTS
Lack of awareness and lack of trained professionals are likely to act as market constraints.
OPPORTUNITIES
The increasing identification of the disease at an early stage has increased the use of the antibody detection test. This in turn will provide more opportunities for blood group typing in APAC region.
CHALLENGES
Unfortunately, the COVID-19 epidemic has led to a drastic drop in voluntary blood donation around the world, due to fears over the safety standards of the equipment used and the imposition of closures in most countries. This is challenging market growth rate in upcoming years.
This research report on the Asia Pacific Blood Group Typing Market has been segmented and sub-segmented into the following categories
By Product:
- Consumables
- Antisera Reagents
- Red Blood Cell Reagents
- Anti-Human Globulin Reagents
- Blood Bank Saline
- Instrument
- Services
By Test Type:
- ABO
- Antigen
- Antibody Screening
- Cross Matching
- HLA
By Technique:
- Assay
- PCR
- Microarray
- Massively Parallel Sequencing
By End User:
- Hospitals
- Clinical Laboratories
- Blood Banks
By Country:
- India
- China
- Japan
- South Korea
- Australia
- New Zealand
- Thailand
- Malaysia
- Vietnam
- Philippines
- Indonesia
- Singapore
- Rest of APAC
REGIONAL ANALYSIS
The Asia region is expected to grow with the highest CAGR due to an increase in the number of traffic accidents and injuries and an increase in the incidence of infectious diseases in this region. For example, according to the WHO, blood donations increased from 2015 to 2019, with 70 million blood donations from unpaid voluntary donors reported between 2015 and 2019. The increase in the number of blood donations and transfusions has thus contributed to the growth of the blood typing market.
The impressive growth rate of the APAC blood group market is driven by promising clinical studies on high-throughput devices, increasing healthcare spending, and increasing number of blood transfusions. in India, the Rotary Blood Bank and the Indian Red Cross said they faced a shocking 82% deficit in blood collection. Such sudden drops in blood donation are likely to have unfathomable effects on patients with conditions such as thalassemia and hemophilia, which require regular blood transfusions. As the efficiency of blood typing mechanisms is highly dependent on blood donation, a decline in these activities will have a negative impact on the growth of the blood typing market.\
Top Companies leading the Asia Pacific Blood Group Typing Market Profiled in the Report are Bio-Rad Laboratories, Inc., Grifols, S.A., Immucor Inc., Ortho Clinical Diagnostics, Inc., Quotient, Ltd., Novacyt Group, BAG Healthcare GmbH, Rapid Labs, Day medical SA, DIAGAST, and AXO Science.
- Introduction
- Market Definition
- Study Deliverables
- Base Currency, Base Year and Forecast Periods
- General Study Assumptions
- Research Methodology
- Introduction
- Research Phases
- Secondary Research
- Primary Research
- Econometric Modelling
- Expert Validation
- Analysis Design
- Study Timeline
- Overview
- Executive Summary
- Key Inferences
- Epidemiology
- Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
- Market Drivers
- Market Restraints
- Key Challenges
- Current Opportunities in the Market
- Market Segmentation
- Product
- Introduction
- Consumables
- Antisera Reagents
- Red Blood Cell Reagents
- Anti-Human Globulin Reagents
- Blood Bank Saline
- Instrument
- Services
- Y-o-Y Growth Analysis, By Product
- Market Attractiveness Analysis, By Product
- Market Share Analysis, By Product
- Test Type
- Introduction
- ABO
- Antigen
- Antibody Screening
- Cross Matching
- HLA
- Y-o-Y Growth Analysis, By Test Type
- Market Attractiveness Analysis, By Test Type
- Market Share Analysis, By Test Type
- Technique
- Introduction
- Assay
- PCR
- Microarray
- Massively Parallel Sequencing
- Y-o-Y Growth Analysis, By Technique
- Market Attractiveness Analysis, By Technique
- Market Share Analysis, By Technique
- End User
- Introduction
- Hospitals
- Clinical Laboratories
- Blood Banks
- Other End Users
- Y-o-Y Growth Analysis, By End User
- Market Attractiveness Analysis, By End User
- Market Share Analysis, By End User
- Geographical Analysis
- Introduction
- Regional Trends
- Impact Analysis
- Y-o-Y Growth Analysis
- By Geographical Area
- By Product
- By Test Type
- By Technique
- By End User
- Market Attractiveness Analysis
- By Geographical Area
- By Product
- By Test Type
- By Technique
- By End User
- Market Share Analysis
- By Geographical Area
- By Product
- By Test Type
- By Technique
- By End User
- China
- India
- Japan
- South Korea
- Australia
- Rest of APAC
- Strategic Analysis
- PESTLE analysis
- Political
- Economic
- Social
- Technological
- Legal
- Environmental
- Porter’s Five analysis
- Bargaining Power of Suppliers
- Bargaining Power of Consumers
- Threat of New Entrants
- Threat of Substitute Products and Services
- Competitive Rivalry within the Industry
- Market Leaders' Analysis
- Bio-Rad Laboratories Inc.
- Overview
- Product Analysis
- Financial analysis
- Recent Developments
- SWOT analysis
- Analyst View
- Grifols S.A.
- Immucor Inc.
- Ortho Clinical Diagnostics Inc.
- Quotient Ltd.
- Novacyt Group
- BAG Healthcare GmbH
- Rapid Labs
- Day medical SA
- DIAGAST
- Competitive Landscape
- Market share analysis
- Merger and Acquisition Analysis
- Agreements, Collaborations, and Joint Ventures
- New Product Launches
- Market Outlook and Investment Opportunities
- Appendix
- List of Tables
- List of Figures
- Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
- Segment-level analysis in terms of Type, by end user along with market size forecasts and estimations to detect key areas of industry growth in detail
- Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
- Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
- Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
- A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
- Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
- An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
- Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
